Coherence Neuro Secures $75 Million Seed Investment From Seraphis Group
Coherence Neuro has secured a $75 million seed investment from Seraphis Group , a New York-based private investment firm founded by Farid Al Rashed . The investment establishes a strategic partnership aimed at acceler…
Coherence Neuro has secured a $75 million seed investment from Seraphis Group, a New York-based private investment firm founded by Farid Al Rashed. The investment establishes a strategic partnership aimed at accelerating the development and commercialization of innovative cancer treatments, combining Coherence Neuro’s work in oncology with Seraphis Group’s healthcare and pharmaceutical expertise. The deal brings Seraphis Group’s total funding to $120 million.
FOUNDERS: Dr. Ben Woodington & Dr. Elise Jenkins
INVESTOR: Seraphis Group
ROUND: Seed AMOUNT: $75,000,000
INVESTOR HQ: New York, New York
#VentureCapital #CoherenceNeuro #SeraphisGroup #TradedPartner #TradedVC
ABOUT THE DEAL
- Raise
- $75M
- Round
- Seed
- Company
- Coherence Neuro
- Desk
- Deals
- Filed
- Nov 19, 2026
- Founders
- Dr. Ben Woodington
- Dr. Elise Jenkins
- Investors